Takasago International Corporation
Takasago International Corp. contributes to life science in supplying high quality pharmaceutical intermediates and powerful catalysts and ligands. We focus on the development of breakthrough technology in the pursuit of achieving Green chemistry. Since we pioneered industrial application of chemo catalysts in 1983 with L-menthol process, involving a Rh-BINAP catalyst. We have intensively developed catalyst and ligands in the area of asymmetric hydrogenation, asymmetric transfer hydrogenation, cross coupling reaction, and applied to manufacturing. Takasago is producing >400MT pharmaceutical intermediates. In 30 years, we have developed >500 catalysts and ligands, 120 of which are commercially available in large scale at >30kg to 1,000kg. We supply cutting-edge catalysts and ligands, which provides increased productivity, lower wastes and/or achieves shorter process.